Shahbaz Bashir

Process Development Engineer @Simabs

SIMABS NV has developed a unique platform for fast, flexible and cost effective development and manufacturing of monoclonal antibodies. The company is redefining the continuous bioprocessing platform for the manufacturing of therapeutic monoclonal antibodies. This platform allows the production of complex antibodies (monoclonal, bispecific, multivalent,…) in a range from milligrams to kilograms for biopharmaceutical companies. This technology will enable affordable personalized medicine to become a reality.